Use of Influenza Vaccination in Patients with moderate or severe Psoriasis

被引：0
|
作者：
Radtke, M. A. [1 ]
Rustenbach, S. J. [1 ]
Purwins, S. [1 ]
Augustin, M. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Inst Versorgungsforsch Dermatol & Pflegeberufen, Hamburg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [31] Influenza Vaccination Recommendations During Use of Select Immunosuppressants for Psoriasis COMMENT
    Kim, Joyce Y.
    Dao, Harry, Jr.
    CUTIS, 2020, 106 (04): : 194 - 195
  • [32] Quantifying cardiovascular risk among patients with moderate to severe psoriasis
    Reich, K.
    Prinz, J.
    Szapary, P.
    Yeilding, N.
    Hsu, M. C.
    Li, S.
    Mrowietz, U.
    Kimball, A. B.
    Menter, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1424 - 1424
  • [33] Etanercept improves symptoms of depression in patients with moderate to severe psoriasis
    Krishnan, R
    Lalla, D
    Woolley, M
    Zitnik, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P184 - P184
  • [34] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Prieto-Perez, Rocio
    Llamas-Velasco, Mar
    Cabaleiro, Teresa
    Solano-Lopez, Guillermo
    Marquez, Beatriz
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Dauden, Esteban
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2017, 18 (02) : 157 - 164
  • [35] Tailored biological treatment for patients with moderate-to-severe psoriasis
    Maurelli, Martina
    Gisondi, Paolo
    Girolomoni, Giampiero
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 37 - 43
  • [36] Evaluation of a psychological group intervention for patients with moderate and severe psoriasis
    Tomas-Aragones, Lucia
    Marron, Servando E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S116 - S116
  • [37] Response to treatment with secukinumab in obese patients with moderate to severe psoriasis
    Krueger, James G.
    Pariser, David
    Muscianisi, Elisa
    Kianifard, Farid
    Steadman, Jennifer
    Sarkar, Rajendra Prasad
    Ehst, Benjamin D.
    Alexis, Andrew F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB38 - AB38
  • [38] Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis
    Leonardi, C
    Goffe, B
    Sobell, J
    Caro, I
    Wang, X
    Papp, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A58 - A58
  • [39] Safety events in moderate to severe psoriasis patients treated with efalizumab
    Ehrlich, Alison
    Caro, Ivor
    Werther, Winifred
    Chen, Yun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB181 - AB181
  • [40] Demographics and Prevalence of Comorbidities for Patients with Mild, Moderate, and Severe Psoriasis
    Hajiebrahimi, Mohammadhossein
    Sundstrom, Anders
    Hagg, David
    McElligott, Sean
    Valgardsson, Sverrir
    Villacorta, Reginald
    Linder, Marie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 379 - 380
12345